Results 201 to 210 of about 18,771 (284)
4-Hydroxymethyl-1-(2,3,4,6-tetra-O-acetyl-β-
Brendan L. Wilkinson+4 more
openalex +2 more sources
A new type of coordination polymer has been discovered while looking for high‐performance, insensitive secondary explosives. This polymer made of scarce imidoyl azide structures, demonstrates interesting pyrotechnic characteristics like a density greater than 2.00 g.cm−3 and great insensitivity towards thermal and mechanical stresses.
Lucas Blanck+4 more
wiley +1 more source
Green and recyclable catalyst based on chitosan/CuFe2O4 nanocomposite hydrogel for one-step synthesis of 1,2,3-triazoles. [PDF]
Ajormal F+4 more
europepmc +1 more source
Various syntheses of cyclooctynes substituted with functional groups capable for hydrogen bonding (amide, imide, carboxylic acid) are reported. These are potential building blocks for surface‐orthogonal molecular architecture on the Si(001) surface.
Dominik Scharf+3 more
wiley +1 more source
Copper-anchored polysulfonamide-modified UiO-66-NH<sub>2</sub>/sodium alginate nanocatalyst for sustainable synthesis of 1,2,3-triazoles. [PDF]
Koosha S, Ghorbani-Vaghei R, Alavinia S.
europepmc +1 more source
Enantioselective Anion‐Binding‐Catalyzed Nucleophilic Addition to 4‐Quinolones
The first organocatalytic enantioselective formal 1,4‐addition to 4‐quinolones has been developed. This method relies on chiral triazole‐based anion‐binding catalysis using enol nucleophiles, complementing previous metal catalytic approaches. Moderate to good yields and enantioselectivities were achieved by in situ silylation and formation of a key ...
Martin Aleksiev+2 more
wiley +1 more source
Germanyl triazoles as a platform for CuAAC diversification and chemoselective orthogonal cross-coupling. [PDF]
Halford-McGuff JM+5 more
europepmc +1 more source
Exploring the Potential and Advancements of Circular RNA Therapeutics
Given the remarkable advantages in terms of stability, sustained expression profile, safety, wide range of druggable targets, scalable and cost‐effective manufacturing capabilities, circRNA is currently undergoing intensive investigation for various therapeutic applications such as vaccines, protein replacement, genetic disease treatment, gene therapy,
Lei Wang+6 more
wiley +1 more source
Efficient Access to New Thienobenzo-1,2,3-Triazolium Salts as Preferred Dual Cholinesterase Inhibitors. [PDF]
Mlakić M+8 more
europepmc +1 more source